United States · FDA National Drug Code directory

rifampin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-2613_f5f4bbb5-c0f8-452a-9ad1-93ca0aab0781
Product NDC
71335-2613
Form
CAPSULE
Composition / generic term
rifampin
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20140108
Source listing expiry
20271231

Source-listed ingredients

  • RIFAMPIN — 300 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE in 1 BOTTLE (71335-2613-1) · 71335-2613-1
  • 60 CAPSULE in 1 BOTTLE (71335-2613-2) · 71335-2613-2
  • 20 CAPSULE in 1 BOTTLE (71335-2613-3) · 71335-2613-3
  • 10 CAPSULE in 1 BOTTLE (71335-2613-4) · 71335-2613-4
  • 70 CAPSULE in 1 BOTTLE (71335-2613-5) · 71335-2613-5

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →